Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-09

FDA Approved: VOLNEA — Supplemental Application (Xiromed, LLC.)

View source ↗

Summary

FDA approved a supplemental application for VOLNEA (desogestrel and ethinyl estradiol) from Xiromed, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOLNEA (Desogestrel and Ethinyl Estradiol)

Snippet

SUPPL AP for VOLNEA (DESOGESTREL AND ETHINYL ESTRADIOL)